Generic placeholder image

Current Psychiatry Reviews

Editor-in-Chief

ISSN (Print): 1573-4005
ISSN (Online): 1875-6441

Recent Advances in Therapy of Schizophrenia

Author(s): Mahesh T. Chhabria and Vishranti D. Trivedi

Volume 7 , Issue 1 , 2011

Page: [25 - 42] Pages: 18

DOI: 10.2174/157340011795945856

Price: $65

Abstract

Despite great progress in basic schizophrenia research, the conclusive identification of specific etiological factors or a pathogenic process in the illness has remained elusive. The convergence of modern neuroscientific studies in molecular genetics, molecular neuropathology, neurophysiology, in vivo brain imaging, and psychopharmacology, however, indicates that we may be coming much closer to understanding the molecular basis of schizophrenia. Schizophrenia may be a neurodevelopmental and progressive disorder with multiple biochemical abnormalities involving the dopaminergic, serotonin, glutamate, and γ-aminobutyric acidergic systems. In the near future, biological markers for the illness may come from the combination of diverse assessment techniques. An understanding of the pathophysiology of schizophrenia will be essential to the discovery of preventive measures and therapeutic intervention. Rapidly advancing research into schizophrenia includes diverse etiological hypotheses, and offers directions for future research and treatments.

Keywords: Schizophrenia, dopamine, serotonin, glutamate, GABA, aminobutyric acidergic systems, biological markers, etiological hypotheses, psychotomimetics, Tourette's syndrome


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy